
Candida auris fungal infections increased 95% in 2021, and drug-resistant cases are continuing to spread across the US.

Candida auris fungal infections increased 95% in 2021, and drug-resistant cases are continuing to spread across the US.

A prominent researcher offers some insights on this emerging fungal infection.

AdventHealth Orlando studied a small number of these fungal isolates to examine treatment resistance patterns.

The emergence of this fungal infection remains mysterious as the world experiences more outbreaks.

With the unpredictability of when it will appear, and its propensity to be multidrug-resistant, this particular pathogen is challenging to diagnose and treat.

This is the first oral non-azole treatment for vaginal yeast infections.